Clinical trials
Phase 3 Autoimmune Diseases trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Human Genome Sciences Inc., a GSK Company | 2 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Human Genome Sciences Inc. | 1 |
| Janssen Biotech, Inc. | 1 |
| La Jolla Pharmaceutical Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 7 |
| Lupus Erythematosus, Systemic | 5 |
| Immune System Diseases | 3 |
| Arthritis | 1 |
| Arthritis, Rheumatoid | 1 |
| Connective Tissue Diseases | 1 |
| Lung Diseases, Interstitial | 1 |
| Lupus Nephritis | 1 |
| Scleroderma, Diffuse | 1 |
| Scleroderma, Systemic | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.